LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Clinical trials for LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo trial offers hope for advanced lung cancer patients
Disease control Recruiting nowThis study is testing whether adding SHR2554 tablets to other cancer treatments is safe and effective for people with advanced non-small cell lung cancer. Researchers will enroll 200 adults to see if this combination helps shrink tumors and control the disease. The trial focuses …
Matched conditions: LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 23:11 UTC
-
New lung cancer pill enters first human trials
Disease control Recruiting nowThis is the first study in people testing a new oral medication called AST2303 for advanced non-small cell lung cancer. The main goals are to find a safe dose, understand how the body processes the drug, and look for early signs that it might help shrink tumors. The study will en…
Matched conditions: LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Allist Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists test new weapon combo against tough lung cancer
Disease control Recruiting nowThis early-stage trial is testing the safety of combining a targeted drug (trastuzumab deruxtecan) with different immunotherapy drugs, with or without standard chemotherapy. It is for people with advanced non-small cell lung cancer that has a specific marker called HER2. The main…
Matched conditions: LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC